CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-23 | GALLAHUE KIERAN Director | Gift | −7,056 | 3,701 | ||
| 2024-02-23 | GALLAHUE KIERAN Director | Gift | +7,056 | 70,277 | ||
| 2024-02-23 | GALLAHUE KIERAN Director | Sale | −3,058 | $87.61 | $268K | 67,219 |
| 2024-02-23 | GALLAHUE KIERAN Director | Exercise or conversion · Director Stock Option (Right to Acquire) | −7,056 | 0 | ||
| 2024-02-22 | SELLERS ROBERT W.A. SVP, Corporate Controller | Grant or award | +1,998 | 15,085.18 | ||
| 2024-02-22 | Szyman Catherine M. CVP, Critical Care | Grant or award | +8,560 | 43,373.57 | ||
| 2024-02-21 | Chopra Daveen CVP, TMTT | Exercise or conversion | +7,000 | $59.26 | $415K | 30,950 |
| 2024-02-21 | Chopra Daveen CVP, TMTT | Sale | −1,200 | $86.67 | $104K | 29,750 |
| 2024-02-21 | Chopra Daveen CVP, TMTT | Sale | −7,000 | $86.75 | $607K | 22,750 |
| 2024-02-21 | Chopra Daveen CVP, TMTT | Exercise or conversion · Employee Stock Option (Right to Acquire) | −7,000 | 0 | ||
| 2024-02-18 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −188 | $86.10 | $16K | 17,213.21 |
| 2024-02-17 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −150 | $86.10 | $13K | 17,401.21 |
| 2024-02-16 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −207 | $86.04 | $18K | 17,551.21 |
| 2024-02-16 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −174 | $86.04 | $15K | 19,074 |
| 2024-02-16 | Wood Larry L Global President TAVR & Surg | Shares withheld for taxes | −317 | $86.04 | $27K | 213,476.71 |
| 2024-02-15 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion | +27,000 | $36.75 | $992K | 61,813.57 |
| 2024-02-15 | Szyman Catherine M. CVP, Critical Care | Sale | −27,000 | $85.62 | $2.3M | 34,813.57 |
| 2024-02-15 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion · Employee Stock Option (Right to Acquire) | −27,000 | 0 | ||
| 2024-02-13 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion | +20,000 | $36.75 | $735K | 54,813.57 |
| 2024-02-13 | Szyman Catherine M. CVP, Critical Care | Sale | −20,000 | $86.46 | $1.7M | 34,813.57 |
Page 29 of 43 · 841 trades